Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis
- 1 September 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 56 (3) , 932-943
- https://doi.org/10.1046/j.1523-1755.1999.00636.x
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritisAmerican Journal of Kidney Diseases, 1998
- Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisJournal of Neuroimmunology, 1996
- Pentoxifylline Augments but Does Not Antagonize TNFα-Mediated Neuroblastoma Cell Differentiation: Modulation of Calcium Mobilization but Not cAMPBiochemical and Biophysical Research Communications, 1995
- Immunohistochemical Quantitation for Extracellular Matrix Proteins in Rats with Glomerulonephritis Induced by Monoclonal Anti-Thy-1.1 AntibodyNephron, 1995
- Pentoxifylline and Intermittent ClaudicationJournal of Cardiovascular Pharmacology, 1995
- Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis.Journal of Clinical Investigation, 1994
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.Journal of Clinical Investigation, 1991
- Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell linesBiochemical and Biophysical Research Communications, 1991
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988
- PentoxifyllineDrugs, 1987